Asian stocks rose to a three-week high on Wednesday, led by gains in technology issues after Intel's results beat market expectations, while the euro held firm near two-month peaks against a softer U.S. dollar.
New AIDS plans released by the United Nations and the U.S. government on Tuesday stress smarter, targeted spending as a way to keep up the fight against the pandemic during a global recession.
Yum Brands Inc , parent of the KFC, Taco Bell and Pizza Hut chains, issued a disappointing full-year earnings outlook and said it expects labor costs to rise in its key China market, sending its shares down 3.2 percent.
The Australian Dollar has opened over one US cent higher this morning and is trading above USD0.8800.
The Australian Dollar climbed to its highest level in 3 weeks overnight as equities bounced upon expectations US corporate earnings will beat estimates.
CME Group Inc CEO Craig Donohue told employees he is pleased with many of the provisions in Washington's financial reform bill, but raised concerns about the leeway it gives regulators.
A new domestic AIDS policy rolled out by the White House on Tuesday asks states and federal agencies to find ways to cut new infections by 25 percent, get more patients treated quickly and educate Americans about the deadly and incurable virus.
The U.S. Commodity Futures Trading Commission risks hurting markets if it is too aggressive in flexing its regulatory muscle to rein in high-frequency traders, exchanges and participants are expected to tell the agency on Wednesday.
Intel Corp , the world's biggest microchip maker, handily beat second-quarter sales and profit estimates and forecast third-quarter sales well ahead of Wall Street's consensus.
JPMorgan Chase & Co, an underperformer so far this year, is one of several big banks whose shares could be poised for a revival now that U.S. financial regulatory reform is all but completed.
Stocks rallied for a sixth straight day on Tuesday after Alcoa's quarterly results heartened investors that had fled to the sidelines on jitters about the sustainability of the economic recovery.
Hedge funds and private equity firms had an easier time raising capital in the last three months, but the market for asset-backed securities remains crippled, according to a new Federal Reserve survey.
Senate Democrats on Tuesday appeared to nail down the votes needed to approve a historic overhaul of U.S. financial regulations and moved to set up a final vote on it by the end of the week.
Shares of bond insurer MBIA Inc and bailed-out insurer American International Group Inc soared on Tuesday after Bruce Berkowitz's Fairholme Capital Management disclosed new stakes in the companies.
A new domestic AIDS policy rolled out by the White House on Tuesday looks for new ways to educate Americans about the deadly and incurable virus, cut new infections by 25 percent and get more patients treated quickly.
Stocks rallied on Tuesday after Alcoa's quarterly results heartened investors that had been pushed to the sidelines by jitters about the sustainability of the economic recovery.
Investor worries that the year-old economic recovery is getting shaky have driven down U.S. manufacturer shares over the past two months.
Cuts in global aluminum production, especially in China, should boost the metal's price and improve U.S. producer Alcoa Inc's earnings prospects, analysts said on Tuesday.
The trading of claims in bankruptcy cases fell to $2.1 billion in June, down for the second straight month, as several large companies prepared to exit Chapter 11, according to data released on Tuesday.
Senate Democrats on Tuesday appeared to nail down the votes needed to approve a historic overhaul of U.S. financial regulations and moved to set up a final vote on it by the end of the week.
European Union finance ministers agreed on Tuesday to increase monitoring of member states' economies from January as part of efforts to tighten budget discipline and prevent new economic crises.
GlaxoSmithKline Plc insisted its diabetes pill Avandia was safe as U.S. advisers began a two-day meeting to consider if the medicine is too dangerous to stay on the market.